PT-141 10mg/Vial Sexual Stimulation Hormone Peptides C50H68N14O10

Sexual Stimulation Peptide PT-141 (10 mg/Vial) / 100% Safe Delivery Guaranteed

Description:

PT-141 was developed from Melanotan 2 (MT-II). PT-141 is a metabolite of melanocyte

stimulating hormone that targets desire.PT-141 is the only synthetic aphrodisiac. The aphrodisiac

effects of PT-141 are in a class of its own. Studies have shown PT-141 to be effective in treating

sexual dysfunction in both men (erectile dysfunction or impotence) and women (sexual arousal

disorder).

PT-141 or Bremelanotide is the generic term for a research peptide being studied for its

possible use in helping to improve sexual dysfunction in both men (erectile dysfunction or

impotence) and women (sexual arousal disorder). PT-141 was developed from the tanning

peptide Melanotan 2, which is a synthetically produced variant of a peptide hormone naturally

produced in the body that stimulates melanogenesis that is known as alpha-Melanocyte

stimulating hormone. MSH, activates certain melanocortin receptors in the process of exerting its

effects. Indeed, MSH also exerts potent influence over lipid metabolism, appetite, and sexual

libido. Resultantly, PT-141 has been shown in studies to exhibit libido-enhancing effects by

activating the melanocortin receptors MC1R and MC4R, but not skin tanning. Melanotan 1 and

Melanotan 2 have been researched for their use in protecting against the harmful effects of

ultraviolet radiation from sunlight due to their melanogenesis-stimulating properties.

Application:

PT-141 functions by activating the melanocortin receptor and MC4R namely. Bremelanotide

originally was tested for nasal spray delivery but was discontinued after concerns about side

effects. Bremelanotide PT141, as Melanotan II, may cause spontaneous arousal enhancing

effect. Unlike other supplements, PT-141 results do not act on the vascular body, but directly

increases desires through the nervous system.

PT-141 and Sexual Dysfunction:

PT-141 is a potential remedy for the treatment of sexual dysfunction; specifically, male erectile

dysfunction. Studies have shown that PT-141 does not act on the vascular system like former

compounds, but allegedly works by activating melanocortin receptors in the brain, therefore

helping increase ones sexual stimulation. PT-141 is a melanocortin based peptide that has

shown effectiveness in clinical studies on both male and female rats. Male rats have shown

erectile response with doses as low as 1-2 mgs whereas most female rats have shown positive

results with higher doses around 2-3 mgs. While the dosage requirements tend to be higher for

female rats, the observable results in female rats tend to be stronger.

The Development of PT-141:

PT-141 was developed from the Melanotan 2 Peptide, which underwent testing as a sunless

tanning agent. In initial testing, Melanotan 2 did induce tanning, but additionally caused sexual

arousal and spontaneous erections as unexpected side effects in nine out of the ten original male

volunteer test subjects. Palatin completed patient treatment in its Phase 2B clinical trial in

premenopausal women with FSD Primary data analysis and announcement of top-line results

anticipated in first-half of fourth quarter of calendar year 2012. In studies, PT-141 was shown to

be effective in treating sexual dysfunction in both men (erectile dysfunction or impotence) and

women (sexual arousal disorder). Unlike and other related medications, it does not act

upon the vascular system, but directly increases sexual desire via the nervous system.

Any need pleace Contact Allen:

Whatsapp:+8618971485175

Email:allenraws0437@gmail.com